Journal
JOURNAL OF PERINATOLOGY
Volume 32, Issue 6, Pages 466-468Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/jp.2011.132
Keywords
Sivelestat; preterm labor; chorioamnionitis; intrauterine infection; intrauterine inflammation
Categories
Ask authors/readers for more resources
Intrauterine infection and inflammation are recognized as major contributors to the onset of preterm labor. We describe two cases of severe preterm labor with bulging membrane that were treated by intravenous injection of Sivelestat, a neutrophil elastase inhibitor. Ritodrine hydrochloride and magnesium sulfate were intravenously administered for tocolysis, and ampicillin was provided as an antibiotic. Urinary trypsin inhibitor (UTI) was administered transvaginally. Sivelestat was infused intravenously at 4.8 mg kg(-1) day(-1) through the maternal vein. No side effects were observed. Levels of interleukin (IL)-6 and IL-8 in amniotic fluid decreased, and gestations were prolonged without complications for >1 week. Two healthy infants were delivered. Our experience suggests that multidrug therapy with Sivelestat offers a new therapeutic strategy for preterm labor, but further investigations of the indications, administration period and dosage are required. Journal of Perinatology (2012) 32, 466-468; doi:10.1038/jp.2011.132
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available